DCGI gave this necessary direction after the National
Institute of Biologicals or NIB in Noida figured out that various manufacturers
of 4th generation HIV in-vitro diagnostics kits are not mentioning the
sensitivity required for HIV P-24 antigen on the product. This delays the
required evaluation of the diagnostic kits.
Taking this on a serious note, Dr. VG Somani, the DCGI, asked
all the licensees to do upgradation of the product insert and include the
analytical sensitivity for HIV 24
antigen to make sure the evaluation is done correctly.
HIV is a virus that attacks the immune system of the human
body. When left untreated, it leads to AIDS. When someone is exposed to HIV,
the human body produces an antigen called P-24. This protein is found in those
people having an acute infection. It triggers the immune system to respond to
the disease. The fourth-generation test can recognize both HIV-specific antigen
P-24 and HIV antibodies with the sample of blood. This helps in identifying the
virus much sooner than early tests.
With a fourth-generation test, HIV can be easily detected
within a span of four weeks after the person has acquired infection. It helps
in the early treatment of the disease. Because of early detection and its
treatment, people who have HIV can live a lengthy as well as healthy life.
NIB is considered as the Central Medical Device Testing
Laboratory under rule 19 of Medical device rules 2017. It carries out all tests
as well as evaluation of all in-vitro diagnostics for human immunodeficiency
virus, hepatitis B surface antigen and Hepatitis C virus, blood grouping sera,
fully automated analyzer based glucose reagent.
Comments
Post a Comment
Please do not enter any spam link in the comment box